The memorial delirium assessment scale

…, B Rosenfeld, A Roth, MJ Smith, K Cohen… - Journal of pain and …, 1997 - Elsevier
We conducted two studies with medically hospitalized cancer and acquired immunodeficiency
syndrome (AIDS) patients to assess the reliability and validity of a new measure of …

Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity

…, J Buse, L Tamaritz, A Palacio, K Cohen… - Journal of medical …, 2021 - Wiley Online Library
Observational studies suggest outpatient metformin use is associated with reduced mortality
from coronavirus disease‐2019 (COVID‐19). Metformin is known to decrease interleukin‐6 …

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

…, KG Jubilo, J Samranvedhya, M Lipsitch, K Cohen - Bmj, 2021 - bmj.com
Objective To evaluate the excess risk and relative hazards for developing incident clinical
sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. Design …

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

…, DV Sahani, SP Kalva, SV Kozin, M Mino, KS Cohen… - Nature medicine, 2004 - nature.com
The effects of vascular endothelial growth factor (VEGF) blockade on the vascular biology of
human tumors are not known. Here we show here that a single infusion of the VEGF-specific …

Long-term outcomes in use of opioids, nonpharmacologic pain interventions, and total costs of spinal cord stimulators compared with conventional medical therapy for …

…, PE Morin, DL Spencer, RF Redberg, K Cohen - JAMA …, 2023 - jamanetwork.com
Importance Spinal cord stimulators (SCSs) are increasingly used for the treatment of chronic
pain. There is a need for studies with long-term follow-up. Objective To determine the …

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

…, RS Call, R Canadas, LB Chaykin, K Cohen… - The Lancet, 2017 - thelancet.com
Background Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose
metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In …

[BOOK][B] The way of qigong: The art and science of Chinese energy healing

KS Cohen - 1999 - books.google.com
… "Ken Cohen is a rare combination of expert practitioner, gifted scholar, and lucid writer. He
… For those interested in optimal health, Ken Cohen's book allows you an opportunity not only …

[HTML][HTML] Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind …

…, JM Nicklas, MA Puskarich, K Cohen… - The Lancet Infectious …, 2023 - thelancet.com
Background Post-COVID-19 condition (also known as long COVID) is an emerging chronic
illness potentially affecting millions of people. We aimed to evaluate whether outpatient …

[PDF][PDF] AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients

…, E di Tomaso, WT Zhang, DG Duda, KS Cohen… - Cancer cell, 2007 - cell.com
Using MRI techniques, we show here that normalization of tumor vessels in recurrent
glioblastoma patients by daily administration of AZD2171—an oral tyrosine kinase inhibitor of …

[HTML][HTML] Phase II study of cediranib, an oral pan–vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

…, T Benner, DN Louis, KS Cohen… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Glioblastoma is an incurable solid tumor characterized by increased expression of
vascular endothelial growth factor (VEGF). We performed a phase II study of cediranib in …